Carol Fabian, MD: Clinical Trials

16 trials sponsored by Carol Fabian, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 terminated, 1 recruiting, 1 withdrawn. 6 Phase 2, 3 Early Phase 1, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Terminated 1
Early Phase 13Completed 2, Terminated 1
Not applicable3Completed 3

Follow Carol Fabian, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
bazedoxifene plus conjugated estrogens - Increased Risk for Development of Breast Cancer
Early Phase 1CompletedCarol Fabian, MD162021-12-022025-10-29
Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms
DUAVEE 0.45Mg-20Mg Tablet - Focus of Study is Healthy Women at Risk for Breast Cancer
Early Phase 1TerminatedCarol Fabian, MD112020-06-012021-10-29
High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women
Supervised Exercise, Home-based Exercise, Reduced Energy Diet - Breast Cancer Female
Not applicableCompletedCarol Fabian, MD112017-09-252024-12-18
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
DHA, Placebo - Cognitive Dysfunction
Early Phase 1CompletedCarol Fabian, MD242015-07-012022-01-24
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Omega-3 Fatty Acids, Placebo Capsule, Diet and Exercise - Breast Cancer
Not applicableCompletedCarol Fabian, MD462014-03-012022-01-24
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
Placebo, secoisolariciresinol - Breast Cancer
Phase 2TerminatedCarol Fabian, MD1802011-01-012023-09-21
Breast Cancer Risk Biomarkers in Premenopausal Women
Lovaza™ - Breast Cancer
Phase 2CompletedCarol Fabian, MD362010-11-012016-07-21
Breast Cancer Risk Biomarkers in Postmenopausal Women
Lovaza™ - Breast Cancer
Phase 2CompletedCarol Fabian, MD352010-11-012016-12-16
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
vitamin D3 - Breast Cancer
Not applicableCompletedCarol Fabian, MD302009-05-012016-07-18
Study of Breast Cancer Prevention by Letrozole in High Risk Women
Letrozole, Placebo - Breast Cancer
Phase 2CompletedCarol Fabian, MD552006-10-012023-06-12
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
Breast Cancer
CompletedCarol Fabian, MD2292005-10-012012-02-07
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
Breast Cancer
CompletedCarol Fabian, MD2812005-06-012023-05-22
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
Fine needle aspiration - Breast Cancer
WithdrawnCarol Fabian, MD2005-05-012019-10-10
Protocol for Women at Increased Risk of Developing Breast Cancer
celecoxib, placebo - Breast Cancer
Phase 2CompletedCarol Fabian, MD722003-04-012016-11-07
Protocol for Women at Increased Risk of Developing Breast Cancer
letrozole - Breast Cancer
Phase 2CompletedCarol Fabian, MD422003-01-012016-06-15
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
Breast Cancer
RecruitingCarol Fabian, MD30001989-08-012025-10-29

Conditions studied

Breast Neoplasms (14)  ·  Breast Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Hyperplasia (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Weight Loss (1)

Interventions

Docosahexaenoic Acids (2)  ·  Estrogens, Conjugated (USP) (2)  ·  Letrozole (2)  ·  Omacor (2)  ·  bazedoxifene (2)  ·  Biopsy, Fine-Needle (1)  ·  Celecoxib (1)  ·  Cholecalciferol (1)  ·  Diet (1)  ·  Eicosapentaenoic Acid (1)  ·  Exercise (1)  ·  Fatty Acids, Omega-3 (1)  ·  secoisolariciresinol (1)

Countries

United States (15)

Top investigators

Carol J Fabian, MD (9)  ·  Carol J. Fabian, M.D. (1)

Results publications

PMID 17221152, PMID 17484269, PMID 32312713, PMID 34244155, PMID 34638355

NIH funding

R01CA122577 (1)